Industry Groups Expand #WearSunscreen Campaign

Why It Matters

Increasing daily sunscreen adoption could prevent the majority of melanomas, reducing healthcare costs and mortality. The coordinated campaign signals a unified industry push that may shift consumer behavior and influence regulatory focus on sun‑safety products.

Key Takeaways

• Daily sunscreen use prevents 90% of melanomas
• Only 14% of Americans apply sunscreen daily
• Coalition includes CHPA, PCPC, melanoma foundations
• Campaign leverages healthcare, retail, policy channels
• FDA‑regulated sunscreens proven to reduce skin cancer risk

Pulse Analysis

Skin cancer remains the most common malignancy in the United States, accounting for over five million diagnoses annually and driving substantial medical expenditures. Epidemiological studies consistently link regular sunscreen application to a dramatic reduction in melanoma incidence, with some estimates suggesting that more than 90 % of cases are preventable through proper UV protection. Yet consumer surveys reveal that only about one in seven Americans applies sunscreen every day, a gap that reflects lingering misconceptions about efficacy, cost, and suitability for different skin tones. Closing this behavior gap is a clear public‑health priority.

The #WearSunscreen initiative brings together the Consumer Healthcare Products Association, its Health In Hand Foundation, the Personal Care Products Council, and leading melanoma‑focused nonprofits, creating a rare cross‑sector alliance. By pooling resources across healthcare providers, retail chains, and advocacy groups, the campaign can deliver consistent, science‑backed messaging at the point of purchase and during medical visits. The inclusion of both mineral and chemical FDA‑regulated sunscreens underscores the industry's commitment to product safety and efficacy, while the multi‑channel rollout—spanning digital media, in‑store displays, and policy outreach—aims to normalize sunscreen as a daily skincare staple.

If the campaign succeeds in raising daily sunscreen use even modestly, the downstream health and economic benefits could be sizable. Dermatologists estimate that each percentage‑point increase in regular use could avert thousands of melanoma cases, translating into lower treatment costs and fewer lost workdays. For manufacturers, heightened consumer awareness may accelerate innovation in broad‑spectrum, reef‑safe formulations and expand market share in the $10 billion sunscreen segment. Ultimately, the coordinated effort signals that sun safety is moving from niche advice to a mainstream public‑health imperative.